NetraMark Holdings Inc. (TSX:AIAI)

Canada flag Canada · Delayed Price · Currency is CAD
0.920
-0.020 (-2.13%)
At close: Mar 6, 2026
-29.77%
Market Cap 84.85M
Revenue (ttm) 165.26K
Net Income (ttm) -5.80M
Shares Out 92.22M
EPS (ttm) -0.07
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 37,017
Average Volume 34,378
Open 0.930
Previous Close 0.940
Day's Range 0.880 - 0.930
52-Week Range 0.820 - 1.800
Beta 1.48
RSI 39.57
Earnings Date May 13, 2026

About NetraMark Holdings

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada. [Read more]

Sector Healthcare
Founded 2016
Country Canada
Stock Exchange Toronto Stock Exchange
Ticker Symbol AIAI
Full Company Profile

Financial Performance

In fiscal year 2025, NetraMark Holdings's revenue was 432,495, a decrease of -5.18% compared to the previous year's 456,127. Losses were -5.22 million, 56.7% more than in 2024.

Financial Statements

News

There is no news available yet.